Exane Derivatives’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $119K | Buy |
799
+95
| +13% | +$14.2K | 0.07% | 248 |
|
|
2022
Q1 | $120K | Buy |
704
+108
| +18% | +$18.4K | 0.03% | 443 |
|
|
2021
Q4 | $154K | Buy |
596
+63
| +12% | +$16.2K | 0.04% | 388 |
|
|
2021
Q3 | $145K | Buy |
533
+185
| +53% | +$50.5K | 0.03% | 456 |
|
|
2021
Q2 | $72.3K | Sell |
348
-630
| -64% | -$131K | 0.02% | 572 |
|
|
2021
Q1 | $107K | Hold |
978
| – | – | 0.03% | 405 |
|
|
2020
Q4 | $79.7K | Buy |
+978
| New | +$79.7K | 0.02% | 414 |
|